The impact of neoadjuvant prednisone on grade and proliferation indices in canine cutaneous mast cell tumors: A pilot study


To determine if administering prednisone prior to surgery affects the factors used to define the grade of mast cell tumors, and thus potentially affects prognosis and treatment recommendations.

Study Progress Update

We have completed enrollment for this study. Thank you to all those who participated.

If you have questions about your participation in the study or about the study results, please contact us:


Ms. Mindy Quigley, Clinical Trials Coordinator
Office Phone: 540-231-1363 | Email: